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Background: Adherences to treatments that require a behavioral action often rely on self-reported recall, yet it is
vital to determine whether real time self reporting of adherence using a simple logbook accurately captures
adherence. The purpose of this study was to determine whether real time self-reported adherence is an accurate
measurement of device usage during a clinical trial by comparing it to electronic recording.
Methods: Using data collected from older adult men and women (N=135, mean age 82.3 yrs; range 66 to 98 yrs)
participating in a clinical trial evaluating a vibrating platform for the treatment of osteoporosis, daily adherence to
platform treatment was monitored using both self-reported written logs and electronically recorded
radio-frequency identification card usage, enabling a direct comparison of the two methods over one year.
Agreement between methods was also evaluated after stratification by age, gender, time in study, and cognition
status.
Results: The two methods were in high agreement (overall intraclass correlation coefficient = 0.96). The agreement
between the two methods did not differ between age groups, sex, time in study and cognitive function.
Conclusions: Using a log book to report adherence to a daily intervention requiring a behavioral action in older
adults is an accurate and simple approach to use in clinical trials, as evidenced by the high degree of concordance
with an electronic monitor.
Trial registration: Clinicaltrials.gov NCT00396994Background
Adherence to treatment, whether in clinical trials or
clinical practice, is important to monitor because the full
benefit of a treatment regimen may only be understood
and achieved if the regime is followed [1-5]. Poor treat-
ment adherence for approved medical interventions can
lead to exacerbation of disease and other declining health
conditions, avoidable hospitalizations, drug- resistance,
and higher costs for both patients and providers [2,3,5-10].
In fact, the U.S. costs of managing poor adherence have
been estimated to be as much as $100 billion annually
[2,3,6]. In clinical trials, poor adherence makes it difficult* Correspondence: Kiel@hsl.harvard.edu
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reproduction in any medium, provided the orto draw conclusions about the implications of a trial or
treatment, as results may be dose-dependent or rely
heavily on a strict adherence to a prescribed regimen
[1,3-5,8]. Without knowing the optimal way to monitor
adherence, one cannot accurately interpret the results of
clinical trials or properly treat patients [1,7].
Adherence to treatment is monitored by various meth-
ods including self-report, proxy report, observation, and
in the case of medication use, by pill counts and more
recently by Medication Event Monitoring Systems (MEMS)
pill bottle caps [1,2,7]. MEMS caps serve as a form of
electronicmonitoring by recording when the cap is opened
or pill removed, and have emerged as a preferred, object-
ive standard of adherence monitoring in many clinical
trials.[1]. Similar to these studies focusing on medicationLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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considered as a gold standard to monitor adherence.
In clinical trials, which often rely on self-reported re-
call of adherence, levels of adherence tend to be higher
than what is observed in actual practice once a treat-
ment is approved.[1] Thus there is even more of a need
to be able to monitor adherence when a new treatment
is prescribed. Often clinical trials requiring that parti-
cipants perform a daily action such as exercise, rely on
self-reporting of adherence using approaches such as
diaries or log books that are signed each day that an in-
dividual adheres to the treatment. The accuracy of such
self-reporting in trials has not been investigated because
there is rarely a method of confirming the accuracy of
the log book. The use of electronic adherence monitor-
ing may provide such a measure.
A range of behavioral treatments and devices have be-
come part of the care of older adults with a variety of
chronic diseases (e.g. diet and exercise plans, blood glu-
cose testing devices, TENS units). As the use of treat-
ments involving a behavioral intervention become more
common, monitoring adherence of their implementation
will be as important as monitoring drug adherence. To
date, adherence to treatment with devices has not been
well-studied, particularly in older adults. Therefore the
purpose of this study was to determine the accuracy of a
simple real time reporting of adherence to a behavioral
treatment in a clinical trial with a daily log book by com-
paring it to the gold standard electronic recording via
the use of a radio frequency identification card reader.
The device used in this trial was one that delivered high
frequency, low magnitude, mechanical stimulation to
improve bone mass, and it was delivered in a rando-
mized, sham platform-controlled trial, as previously de-
scribed.[11]
Methods
All aspects of the study were reviewed and approved by
the Institutional Review Board at Hebrew Rehabilitation
Center. The “VIBES” (Vibration to Improve Bone Density
in Elderly Subjects) study is a randomized, double-blind,
sham platform-controlled device trial of the efficacy of
daily low magnitude, high frequency vibration to increase
bone mineral density, balance, muscle mass and strength
in men and women over the age of 60 who reside in in-
dependent living settings, and who have osteopenia of
the hip or spine (between −1 and −2.5 standard deviations
below young normal reference values) at baseline testing.
The sample and the inclusion and exclusion criteria have
been described previously [11], but in general, partici-
pants had an average age of 82.3 years (range 65–103)
and were generally cognitively intact, relatively well-edu-
cated, mostly Caucasian men and women living around
the Boston area. Study participants were recruited from15 independent living facilities and informed consent
was obtained from all.
VIBES participants were asked to stand on a vibrating
platform seven days a week, for ten minutes each day,
for up to three years. The device delivered a vibration
at 30Hz (cycles per second), 0.3g acceleration (where g
is earth’s gravitational field, or 9.8 meters per second
squared). This low magnitude is often described as a
buzzing sensation, and is considered safe by ISO stan-
dards for up to 4 hours each day. The sham group stood
on an identical device that did not deliver this same vi-
bration. There was no scheduled time for treatment on
any given day; participants were simply instructed to use
the device once a day at a time convenient to them. Daily
adherence to study treatment was tracked using both
electronic as well as self-reported written logs. More spe-
cifically, each day when participants used the vibrating
platforms, they were asked to indicate the date and time
of their session in a paper log book. Their session time
on the VIBES platform was also recorded by the machine
itself using unique person-specific radiofrequency identi-
fication (RFID) card system.
Self-reported paper logs
Participants were asked to sign a pre-designed paper log
book at the start of each daily session; the log book was
located in the same room as the platform. Dates were
listed in a column with a row of empty boxes for partici-
pants to initial under their name. On the first study day
of platform use, participants were individually instructed
by research staff to write their initials under their name
on the proper date and to note the approximate time
that they stepped onto the platform. Paper logs were col-
lected bimonthly and manually double entered into a
database over the first year of the clinical trial.
Electronic monitoring
Each platform session was initiated by an assigned RFID
card specific to the person and his or her assigned plat-
form. Sham platforms used in this trial were initiated by
a similar card but participants assigned to these plat-
forms did not receive the prescribed low magnitude vi-
bration. Each participant was given his or her own card
to use and instructed to use only that RFID card. When
the machine was activated, a record was created in the
platform computer memory card containing the date
and time, length of the session, and any interruption
during the 10-minute session. Each platform’s memory
device was periodically downloaded and sent to the data
coordinating center.
Early in the study, while reviewing the RFID recorded
data from several platforms, we observed the occurrence
of multiple sessions by individuals on the same date; fur-
ther, they were recorded as taking place at late hours
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odd hours and duplicate sessions could be accounted for
by a platform clock malfunction in 10 of the 38 plat-
forms at 4 of the 16 study sites and that a simple sub-
traction of 12 hours corrected the problem. It should be
noted that paper logs were used to confirm the 12-hour
clock error. Two additional platforms reported similar
problems but a 12 hour correction did not appear to be
the explanation; instead, comparison with the paper logs
indicated a discrepancy such that one clock time was
ahead by 4.5 hours and the other by 5 hours. A total of
44 out of 136 participants were affected by these adjust-
ments. These errors were corrected and the corrected
data for these observations were retained in the analyses,
as we felt the corrected clock errors would not invalidate
our ability to compare the two methods.
In a few additional cases we discovered that duplicate
sessions recorded by the devices resulted from RFID
card sharing between participants or due to a participant
attempting to do two sessions in one day after missing
the previous day. Unlike the correction of the clock
errors before analysis (noted above), these observations
were not corrected before analysis because they were felt
to be due to the behavior of the individual participants.Participant characteristics
Age was obtained by interview, and height and weight
were measured using a calibrated scale and stadiometer
at baseline. Cognitive status was assessed using the Short
Blessed Test (SBT)[12] during the consenting process.
Time in study was calculated as the number of days
from the first time that a participant logged in or ini-
tiated an electronically recorded session until the last
day the same participant recorded a session by either
method for up to one year of participation. In some
instances the last day occurred because the participant
dropped out (N=2), or because an individual participant
had accumulated less than a year of follow up when the
data were locked for analysis (N=56). a A health pro-
blems list was used to query whether a participant had
been told by a physician in the past year that he/she has
the listed disease or chronic health problem.Analysis
Adherence data were included from participants who
had been in the study between 6 and 12 months. Adher-
ence for both the self-reported paper logs and electron-
ically monitored methods was calculated by dividing the
number of completed sessions by the number of sessions
expected as per protocol. The protocol specified that 10
minute sessions should occur daily; however, since the
paper logs did not include the length of treatment, ad-
herence recorded by the devices was defined as thenumber of sessions initiated relative to the number of
possible sessions.
We used an intraclass correlation coefficient (ICC) to
determine agreement between the two methods of ad-
herence measurement. We used an ICC, rather than the
standard paired intraclass correlation, because the data
were organized by adherence method, rather than paired
measures by individual, and because we were primarily
interested in the similarity of the measured adherence
between methods. ICC was calculated via two-way mixed
effects modelling, treating subject as a random effect and
method of adherence as a fixed effect with a consistency
definition as described by McGraw and Wong.[13]
A priori we hypothesized that the agreement between
self-reported and electronically monitored adherence
recording might differ by sex, age, number of months in
the study, and cognition. Therefore, we stratified the ICC
analyses by age (less than versus greater than or equal to
the median), sex, cognition, based on Short Blessed Test
scores (less than versus greater than or equal to the me-
dian), and time in study. Expecting that adherence might
change over time, we divided the time in study into sev-
eral groups; the minimum required six months participa-
tion time to less than nine months, nine months to less
than twelve months, and twelve months. We used SAS
Version 9.2 (SAS Institute, Cary, NC) for all analyses.
To examine individual level data, we plotted electronic
adherence versus self reported adherence using a Bland-
Altman plot. This plot provided an indication as to
whether the difference (discrepancy) between the two
measures of adherence was related to the level of adher-
ence. (i.e., there is a systematic bias in the measurements)
or the difference was randomly distributed across the
range of adherence (i.e., measurements are unbiased). In-
dividual observations outside of the two standard devia-
tion limits are indicative of particularly large discrepancies.
Results
Table 1 provides a summary of participant characteris-
tics included in the analyses. The study sample was two
thirds women and overwhelmingly Caucasian (n=130,
96.3%). Average age was 82.3 (SD 7.1), with 45% of parti-
cipants ages 84 years or older. Not unexpectedly, since
individuals with impaired cognitive status (Short Blessed
Test >12) were excluded, the Short Blessed scores were
relatively low (mean 2.4, SD 2.7). One quarter of the
sample had 6 but less than 9 months of data, 19% had 9
but less than 12 months of follow up, and 56% of the
sample had 12 months of follow up. On average, partici-
pants had slightly more than 3 health problems.
Two participants were excluded from our study com-
parison due to personal characteristics that interfered
with the study goals. One participant was legally blind
and unable to sign into the paper log sheet, while the
Table 1 Baseline characteristics of 135 participants
included in the VIBES study
Characteristic N (%) or mean (SD)
Percent female 90 (67%)
Age Group
Age < 84 74 (55%)
Age ≥ 84 61 (45%)
Age (yrs) 82.3 (7.1)
Weight, lbs 157.6 (27.7)
Height, in 63.9 (4.0)
Short Blessed Test Score 2.4 (2.7)
Time in Study
6 - <9 Months 34 (25%)
9 - <12 Months 25 (19%)
12 Months 76 (56%)
Time in Study (Months) 10.2 (2.4)
Education
Not a College Graduate 64 (47%)
College Graduate 71 (53%)
Marital Status
Never married/Divorced 24 (18%)
Widow or Widower 65 (48%)
Married 46 (34%)
Number of health problems 3.4 (2.1)
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promised completing the daily attendance log book.
Results for self-reported and electronically monitored
adherence are provided in Table 2. Overall, average elec-
tronic adherence was shown to be 0.76± 0.23 and self-
reported adherence was 0.78± 0.23. Across all subgroups,
self-reported adherence was greater than electronic ad-
herence although these differences were small and not
statistically different. For example, the greatest difference
was observed in participants aged 84 and older, whereTable 2 Comparison of electronic versus self-reported adhere
Subgroup Possible Days Days
Overall 42,098
Age Group Age < 84 22,001
Age ≥ 84 20,097
Gender Male 14,680
Female 27,418
Time in Study 6 - <9 Months 6,830
9 - <12 Months 7,452
12 Months 27,816
Short Blessed Test Score < 2 (Median) 17,889
≥ 2 (Median) 24,209
*refers to the actual number of days recorded using the electronic monitor.
†refers to actual number of days recorded as being adherent on the self-reported lothe mean self-reported adherence was .77± 0.26 while
the electronic log reflected a mean of 0.74±0.26.
Agreement between self reported adherence and elec-
tronically monitored adherence is shown graphically in
Figure 1. In general, we found the two methods to be in
agreement, with an overall intra-class correlation of 0.96.
The same high correlations were observed within differ-
ent age groups, in men and women, time in study, and
in the two categories of scores on the Short Blessed
Test. Subgroup intra-class correlations ranged from 0.93
to 1.00.
Examining individual level data, the Bland-Altman plot
(Figure 2) in figure 2 again displays excellent agreement
with only three observations outside of the “agreement
limits.” These three participants had no distinguishing
characteristics. There was no obvious bias in the differ-
ence by the mean measurements. Thus, the two mea-
surements of adherence were in excellent agreement and
generally reflective of each other.
It is also interesting to note that the device has a built-
in program to deliver 10 minutes of treatment or to
“shut off” when a participant steps off the platform.
When we examined the number of minutes per session
using the electronic monitor data, we observed that par-
ticipants generally remained on the platform for the en-
tirety of the 10 minute session with only 0.5% of
sessions ending prior to the 10 minutes. Twenty three
percent of these occurrences can be attributed to one in-
dividual who routinely cut her sessions short.
Discussion
In this study we compared two approaches to monitor-
ing adherence to an intervention requiring daily attend-
ance for a 10 minute session on a vibrating platform.
One approach relied on self-reported use of the vibrat-
ing platforms via a sign-in logbook, and the other
enlisted RFID card technology to create an electronic
log. As new behavioral interventions become available
for treatment, it is particularly relevant to know whethernce by age group, sex, time in study and cognition
Electronic Adherence Self-Reported Adherence
Recorded* Mean (± SD) Days Reported† Mean (± SD)
31,902 0.76 (± 0.23) 32,678 0.78 (± 0.23)
17,271 0.78 (±0.20) 17,496 0.79 (± 0.19)
14,631 0.74 (±0.26) 15,182 0.77 (± 0.26)
10,969 0.76 (±0.25) 11,247 0.78 (± 0.26)
20,933 0.76 (±0.22) 21,431 0.78 (± 0.21)
5,378 0.79 (±0.22) 5,440 0.80 (± 0.22)
5,358 0.73 (±0.27) 5,622 0.76 (± 0.26)
21,166 0.76 (±0.22) 21,616 0.78 (± 0.22)
14,001 0.78 (±0.20) 14,287 0.80 (± 0.19)
17,901 0.75 (±0.25) 18,391 0.77 (± 0.25)
g book.
00.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
O
ve
ra
ll
A
ge
<
84
A
ge
>
84
M
al
e
F
em
al
e
6
9
M
on
th
s
9
12
M
on
th
s
12
M
on
th
s
<
2
(M
ed
ia
n)
>
=
2
(M
ed
ia
n)
Total Age Group Gender Time in Study SBTScore
A
d
h
er
en
ce
A
g
re
em
en
t
(I
C
C
)
Figure 1 Intraclass correlation with 95% confidence intervals of
agreement between the two methods of adherence according
to age, sex, time in study, and cognition. SBT refers to the Short
Blessed Test.
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may suffice compared to more sophisticated electronic
monitoring approaches.
We found a very high correlation between electronic
and self-reported adherence (ICC = 0.96). While elec-
tronic monitoring of device studies has not been pre-
viously described, electronic recordings of medication
adherence using MEMS caps have been studied, often
in comparison to calendars, journals, or questionnaires
that involve recall of missed doses. Similar to previous
medication-based studies[1,4,8,14-16], our self-reported
adherence rate in this device trial was slightly higher-0.6
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Figure 2 Bland-Altman plot of the difference between
electronically monitored adherence and self-reported
adherence as compared with the mean of the two adherence
measures. The thick black lines indicate 2 SDs above and below the
difference in adherence.than the electronic monitoring approach; however, the
difference was minimal. Of note, self-generated reports
of adherence in this study were created by participants
signing a log book daily for each of their treatment ses-
sions. As previously seen, this method would be expected
to create more accurate reports of adherence than previ-
ous adherence studies that depended on participant’s
retrospective recall of their session.[17]
Devices such as the platforms used in the VIBES trial
are good candidates for electronic monitoring since they
can be equipped with small, internally integrated mem-
ory components, although this may not be typical for
other treatments. While we found excellent agreement
between the two adherence monitoring approaches, ad-
mittedly, there may be good reasons to recommend
using electronic monitoring as a preferred option to self-
reporting when possible. First, electronic monitoring
may reduce subject burden and the possibility for error
as well as prevent inaccurate reporting. Furthermore the
two participants who were excluded from comparison
analyses due to personal characteristics that interfered
with their ability to sign into the paper log sheet, high-
lights that in certain situations electronic monitoring
can overcome physical characteristics that make the use
of log books difficult. Further, device monitoring similar
to that used in the VIBES trial may allow for a more
complete picture of the treatment event, especially when
accurate duration of treatment is desirable. In our case,
electronic monitoring provided data regarding the actual
time spent using the device, revealing one participant
who had been initiating sessions regularly but not com-
pleting the entire 10 minutes specified by the protocol.
The duration of treatment could be requested of self-
reporters as well, albeit with less specificity than elec-
tronic recording provides. In spite of this, electronic
monitoring may not always be feasible. While the re-
duced specificity in adherence tracking inherent in self-
report is not ideal, our results suggest such monitoring
to be sufficient in the tracking of behavioral routines.
While there are advantages to employing electronic
monitoring, it does not come without limitations. On
several occasions the equipment did not initiate a ses-
sion when a participant attempted to start the machine
via the RFID reader. This situation was typically due to
the machine being unplugged, which could be easily
fixed by resetting. Also, as described previously and ob-
served in this study, electronic adherence records would
have been inaccurate had we not solved the device’s
clock malfunction (which required use of the log book
self-reports). Again, this is a potential limitation of elec-
tronic device monitoring systems that would need to be
rectified by improvements in the monitoring hardware
and software. Another limitation to relying on electronic
adherence data was that participants were required to
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(n=12), participants occasionally used a card belonging
to another individual assigned to the same machine, des-
pite being asked not to do so. This situation occurred
typically with spouses who had access to each other’s
cards. These issues should be anticipated in future appli-
cations of this technology so that such practices are
minimized. This may be feasible through alternative
approaches such as body weight detection, cornea scans,
or fingerprints, though the cost may be prohibitive. Due
to these limitations, and based on the high concordance
between use of a log book and an electronic monitoring
approach, the use of a low cost, low tech log book may
be preferred over more complex adherence monitors, es-
pecially in real-world practice settings.
Conclusions
Behavioral interventions that involve a daily commit-
ment are difficult to verify. Previous studies have often
elicited the use of calendars or questionnaires to record
adherence, but these have been shown to be less than re-
flective of actual adherence. We have shown that daily
logs may be an accurate measure of adherence, as veri-
fied with electronically recorded adherence. Log books
provide a simple, low cost, visual reference for partici-
pants and potentially serve as a motivational device as
they display sessions completed and missed. Such re-
minder interventions can immediately and significantly
improve adherence to treatment, even in individuals with
high adherence rates [18]. In turn, this should reduce
the complications often associated with poor adher-
ence, and ultimately, reduce the cost of health care.
While electronic monitors offer the advantage of
being able to record events such as pauses or abbre-
viated sessions, and to overcome errors in self-report-
ing, low cost log books may be sufficient to monitor
adherence. Though remote monitoring of devices can
be expected with the advances in wireless technology
and the internet, for lower tech interventions, log
books can be implemented as an effective tool to
track adherence to behavioral interventions.Competing interest
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